| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 09/28/2000 | CA2367963A1 Hydroxamic and carboxylic acid derivatives |
| 09/27/2000 | EP1038868A2 Sulfonamides as antiviral agents |
| 09/27/2000 | EP1037878A2 Metabotropic glutamate receptor antagonists for treating central nervous system diseases |
| 09/27/2000 | EP1037633A1 Antiviral compounds |
| 09/27/2000 | EP0901465B1 Compounds with anti-inflammatory and immunosuppressive activities |
| 09/27/2000 | CN1267670A Two aporphine-benzyl isoquinoline compounds with antineoplastic activity |
| 09/27/2000 | CN1056832C Fused dihydropyridine derivate, its producing process, and its pharmaceutical composition |
| 09/26/2000 | US6124461 Compounds, compositions, and methods for treating erectile dysfunction |
| 09/21/2000 | WO2000055137A1 Compounds and methods for modulation of estrogen receptors |
| 09/21/2000 | DE19912638A1 Naphthylcarbonsäureamid-substituierte Sulfonamide Naphthylcarbonsäureamid-substituted sulfonamides |
| 09/21/2000 | CA2367895A1 Compounds and methods for modulation of estrogen receptors |
| 09/20/2000 | EP1035843A2 I h?-MODULATORS |
| 09/20/2000 | CN1056602C Esters and amides as PLAZ inhibitors |
| 09/19/2000 | US6121283 N-substituted-6-(2-(4-trifluoromethylphenyl)phenylcarbonyl-amino) -1,2,3,4-tetrahydroisoquinolines; treating disorders including obesity, hyperlipidemia, and diabetes; microsomal triglyceride transfer protein (mtp); apolipoprotein b (apo-b) |
| 09/19/2000 | US6121278 Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity |
| 09/19/2000 | US6119687 Partial liquid breathing of fluorocarbons |
| 09/14/2000 | WO2000024717A3 Isoquinoline derivatives |
| 09/13/2000 | EP1034164A1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 09/12/2000 | US6118010 Catalytic reduction of the 1-alkoxycarbonyl-3-oxo-3-phenylpropyl derivative |
| 09/12/2000 | US6117999 Chemical intermediate for nelfinavir |
| 09/12/2000 | US6117910 Bicyclic fibrinogen antagonists |
| 09/08/2000 | WO2000051971A1 Oxamic acids and derivatives as thyroid receptor ligands |
| 09/08/2000 | WO2000051970A1 Amide compounds for the potentiation of cholinergic activity |
| 09/08/2000 | WO2000034260A3 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group |
| 09/06/2000 | EP1032570A1 Isoquinoline derivatives and their therapeutical use |
| 09/06/2000 | EP1032559A1 Aminoalkylphenol derivatives and related compounds |
| 09/06/2000 | EP1032556A1 Pharmaceutically active compounds and methods of use |
| 09/06/2000 | CN1265669A Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265645A Urokinase inhibitors |
| 09/05/2000 | US6114530 Isoquiolinamines and phthalazinamines useful in treating stress related disorderes such as post traumatic stress disorder as well as depression, headache and anxiety |
| 09/05/2000 | US6114529 Useful for preparing camptothecin derivatives having antitumor activities |
| 09/05/2000 | US6114175 Amyloid-binding compounds which are non-azo derivatives of chrysamine g to determine degree of brain deposits quantitatively characterized by amyloidosis; down's syndrome; prevent cell degeneration; radioactive imaging |
| 08/31/2000 | WO2000050872A2 A system for cell-based screening |
| 08/31/2000 | WO2000050406A1 Isoquinoline derivatives and isoquinoline combinatorial libraries |
| 08/31/2000 | WO2000050389A1 Efficient carbamate synthesis |
| 08/31/2000 | WO2000050377A1 Efficient synthesis of secondary amines by selective alkylation of primary amines |
| 08/31/2000 | WO2000050376A2 Efficient synthesis of alkyl carbonates |
| 08/30/2000 | EP1031563A1 Sulfonyl derivatives |
| 08/29/2000 | US6110934 Substituted benzamide derivatives and their use as anticonvulsants |
| 08/29/2000 | US6110933 Amino acid derivatives and their use as phospholipase A2 inhibitor |
| 08/29/2000 | US6110922 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 08/24/2000 | WO2000015992A3 Tube for lining pipes and channels, and a method and device for the production thereof |
| 08/22/2000 | US6107331 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 08/17/2000 | WO2000047554A2 INHIBITORS OF FACTOR Xa |
| 08/17/2000 | WO2000047553A2 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa |
| 08/17/2000 | CA2362375A1 Alkenyl and alkynyl compounds as inhibitors of factor xa |
| 08/17/2000 | CA2361428A1 Inhibitors of factor xa |
| 08/16/2000 | EP1027336A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors |
| 08/16/2000 | EP1027052A1 Novel combination |
| 08/16/2000 | CN1055468C Alkylaminoindane compounds process for preparing them and pharmaceutical compositions containing them,and use |
| 08/10/2000 | WO2000046204A1 Tetrahydro isoquino linealkanol derivatives and pharmaceutical compositions containing same |
| 08/10/2000 | CA2361805A1 Tetrahydro isoquino linealkanol derivatives and pharmaceutical compositions containing same |
| 08/09/2000 | EP1025090A1 Vitronectin receptor antagonists |
| 08/09/2000 | EP1025087A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 08/09/2000 | EP0820434B1 Phenoxyethylamine derivatives having high affinity for the 5-ht 1a receptor, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing said derivatives |
| 08/09/2000 | CN1262677A Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, noval compounds thereof and their use as chemotherapeutic agents |
| 08/09/2000 | CN1262620A Beta-Alkoxyacrylates against malaria |
| 08/09/2000 | CN1262272A HIV proteinase inhibitor |
| 08/08/2000 | US6100404 Erythromycin compounds |
| 08/08/2000 | US6100277 Retroviral protease inhibitor combinations |
| 08/03/2000 | WO2000044713A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors |
| 08/03/2000 | WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS |
| 08/03/2000 | CA2356346A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors |
| 08/03/2000 | CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 08/02/2000 | EP1023269A1 Beta3-adrenoreceptor agonists, agonist compositions and methods of using |
| 08/02/2000 | EP1023268A1 Isoquinolines as urokinase inhibitors |
| 08/02/2000 | CN1261906A Alkyl, alkenyl and alkynyl chrysamine G derivatives for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| 08/02/2000 | CN1261883A Novel compounds |
| 08/01/2000 | US6096752 Method for the preparation of tertiary amines, a compound useful therefor and alpha-2-receptor active tetrahydroisoquinoline derivatives |
| 08/01/2000 | US6096712 Tripeptide derivative; antiallergens, male contraceptives, antiinflammatory agents, antispasmodics, hypertensive agents |
| 08/01/2000 | CA2209925C 5,6-diaryl-5,6,7,8-tetrahydronaphthalenes and their analogs as estrogen agonists/antagonists |
| 08/01/2000 | CA2019335C Phenylalkan (en)oic acids |
| 07/27/2000 | WO1999057098A3 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
| 07/26/2000 | EP0736011B1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations |
| 07/26/2000 | CN1261350A Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors |
| 07/26/2000 | CN1261278A Methods for treating inflammatory diseases using padprt inhibitors |
| 07/25/2000 | US6093731 Isoquinolines |
| 07/25/2000 | US6093730 Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals |
| 07/25/2000 | US6093729 Substituted bicyclic heteroaroylguanidines, a process for their preparation, their use as a medicament or a diagnostic agent, and a medicament containing them |
| 07/20/2000 | WO2000042071A2 Compounds and methods to inhibit or augment an inflammatory response |
| 07/20/2000 | CA2697598A1 Compounds and methods to inhibit or augment an inflammatory response |
| 07/19/2000 | EP1020445A1 Fused pyridine derivatives |
| 07/19/2000 | EP1019367A1 Derivatives of 2,5- and 3,5-disubstituted anilines, their preparation and use |
| 07/19/2000 | EP0902781A4 Preparation of (s)-decahydroisoquinoline-3-carboxylic acid t-butylamide |
| 07/13/2000 | WO2000040560A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 07/12/2000 | EP1017664A1 C3a receptor ligands |
| 07/12/2000 | EP1017382A1 Biarylalkanoic acids as cell adhesion inhibitors |
| 07/06/2000 | WO2000039081A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 07/06/2000 | WO2000039070A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | CA2358315A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/05/2000 | EP1015444A1 Novel pyrimidine derivatives and processes for the preparation thereof |
| 07/05/2000 | EP1015432A1 Separation of enantiomers of octahydroisoquinoline |
| 07/05/2000 | CN1259126A Pharmacological agents |
| 07/05/2000 | CN1259119A Substituted 3,3-diamino-2-propenenitriles their preparation and use |
| 07/04/2000 | US6084120 β-Alkoxyacrylates against malaria |
| 06/29/2000 | WO2000037429A2 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 06/28/2000 | EP1012166A1 1-amino-7-isoquinoline derivatives as serine protease inhibitors |
| 06/28/2000 | EP1012145A1 Alkoxy-substituted compounds, methods, and compositions for inhibiting parp activity |
| 06/28/2000 | EP1011651A1 Method of treating diabetes and related disease states |
| 06/28/2000 | CN1053899C Acylguanidine, its preparation process and use, and pharmaceutical composition contg. same |